Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, Ontario, CanadaDr. Peter Lin began his studies in the Faculty of Science and Engineering at the University of Toronto in Toronto, Ontario. Midway through, he moved to the Faculty of Medicine, where he completed his studies and became involved in research. Over the years, it became apparent to him that there was a wide chasm between research and clinical practice, and he moved into clinical practice in primary care and eventually into teaching in order to help bridge this gap. He served as the medical director at the Health & Wellness Centre, University of Toronto Scarborough, for 7 years.
Currently, Dr. Peter Lin is the Director of Primary Care Initiatives at the Canadian Heart Research Centre. He is also a contributing author to the Canadian Diabetes Guidelines 2013 and 2018 on the vascular protection section. He is also Associate Editor for the Elsevier WebPortal - PracticeUpdate Primary Care. He lectures and speaks internationally on a variety of topics. Dr. Lin has worked with KDIGO in order to help improve care for CKD patients. He has also been tracking and providing information on COVID-19 to the public since the beginning of the pandemic. Dr. Lin received a teaching award from the College of Family Physicians in 2011.
Disclosures
Dr. Lin has consulted with the following companies on Continuing Medical Education programs:Astrazeneca, Boeringher Ingelheim, Bayer, Eli Lilly, Amgen, Janssen, Merck, Pfizer, Sanofi, Abbott, HLS Therapeutics Inc.
No clinical trials. No patents.
Recent Contributions to PracticeUpdate:
- Bioprosthetic vs Mechanical Aortic Valve Replacement
- Home Modifications to Reduce Fall Injuries
- Self-Reported Memory Complaints Associated With Risk for Future Cognitive Impairment
- Thiopurines Associated With Non-Melanoma Skin Cancer in Ulcerative Colitis
- Severe Hypoglycemia Associated With Adverse Macrovascular Events in T2DM
- GLP-1 Receptor Agonist and Basal Insulin Combination Effective for T2DM Treatment
- HDL Cholesterol Inversely Related to Cancer Risk in Patients With T2DM
- Angiotensin–Neprilysin Inhibition vs Enalapril in Heart Failure
- Medications of Questionable Benefit in Advanced Dementia
- Antimicrobials Associated With Hypoglycemia in Older Patients Taking Sulfonylureas